Xi'an Century Shenkang Pharmaceutical

Xi'an Century Shenkang Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and production of treatments for chronic kidney disease and cardiovascular conditions. The company is best known for its flagship product, Shenkang Injection, which is a leading modern traditional Chinese medicine (TCM) therapy for chronic renal failure in the Chinese market. Founded in 2001 and based in Xi'an, the company maintains high-standard manufacturing facilities for both injectables and oral formulations. In 2015, it was acquired by China Resources Sanjiu Medical & Pharmaceutical, a major state-owned enterprise, to serve as a core component of its nephrology business unit. The company's products are integrated into major hospital procurement lists across China, reflecting its strong clinical reputation.